Leading Russian drug producers call for state support measures

23 January 2015
moscow-big

Leading Russian drug producers have called on the national parliament (State Duma) for a complex of measures aimed at stabilizing the current situation in the market.

According to the drugmakers, the current situation in the market remains serious, and is reflected by the ever increasing drug prices in Russia, as well as the growing shortage of drugs, especially cheap ones, in the local market.

One of the major reasons for this is the production of domestic drugs from imported substances, prices for which in recent months have significantly increased and the growth of other costs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical